Company: DHR
Filing Date: 2025-02-20
Form Type: 10-K
Source: 0000313616-25-000043
Chunk: 207

Company: DANAHER CORP /DE/
Filing Date: 2025-02-20
Form: 10-K
Item: Item 5
Chunk 207
---
 Biotechnology businesses and the development of diagnostics testing technologies and the expansion of testing production capacity at certain of the Company’s Diagnostics businesses.  The Company’s businesses may enter into similar agreements in the future.  In consideration of this financing, the U.S. government has certain rights, including rights with respect to the allocation of certain of the incremental production capacity associated with such expansion and/or rights in intellectual property produced with its financial assistance.  The amount awarded pursuant to these grants in 2021 totaled $568 million and is being paid over periods ranging from one year to four years.  In 2024, 2023 and 2022, the Company recorded amounts related to these grants and other government assistance that offset operating expenses of $43 million, $51 million and $49 million, respectively, and purchases of property, plant and equipment of $198 million, $136 million and $87 million, respectively.  Property, plant and equipment purchased using funds provided by governments are recorded net of government assistance. 

65

In June 2022, the FASB issued ASU No. 2022-03, Fair Value Measurement of Equity Securities Subject to Contractual Sale Restrictions.  The ASU clarifies the guidance in ASC 820, Fair Value Measurement, related to the measurement of the fair value of an equity security subject to contractual sale restrictions and introduces disclosure requirements related to such equity securities.  The Company early adopted the ASU effective July 1, 2022 and the impact of the adoption was not significant.In August 2023, the FASB issued ASU 2023-05, Business Combinations—Joint Venture Formations (Subtopic 805-60): Recognition and Initial Measurement.  The ASU requires that a joint venture apply a new basis of accounting upon formation in which the joint venture will recognize and initially measure its assets and liabilities at fair value (with exceptions to fair value measurement that are consistent with the business combinations guidance).  The ASU is effective prospectively for all joint venture formations with a formation date on or after January 1, 2025, with early adoption permitted.  The Company early adopted the ASU effective September 30, 2023 on a prospective basis. In November 2023, the FASB issued ASU 2023-07, Improvements to Reportable Segment Disclosures.  The ASU requires additional disclosures about reportable segments’ significant expenses on an interim and annual basis.  The Company adopted the ASU effective January